Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Mclean Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Dost Ongur, Mclean Hospital
ClinicalTrials.gov Identifier:
NCT01688765
First received: September 17, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
  Purpose

The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.


Condition
Psychotic Disorders

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

Resource links provided by NLM:


Further study details as provided by Mclean Hospital:

Estimated Enrollment: 200
Study Start Date: October 2012
Groups/Cohorts
First Episode Psychosis Patients
Healthy Controls

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

First episode psychosis patients Healthy controls

Criteria

Inclusion Criteria:

  • Clinical diagnosis of first episode of a psychotic disorder
  • Healthy controls with no psychiatric disorder history

Exclusion Criteria:

  • Significant neurological or medical illness history
  • Ages <18 or >45
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01688765

Locations
United States, Massachusetts
McLean Hospital Not yet recruiting
Belmont, Massachusetts, United States, 02478
Contact: Samira Pingali    617-855-2370    spingali@mclean.harvard.edu   
Sponsors and Collaborators
Mclean Hospital
  More Information

No publications provided

Responsible Party: Dost Ongur, M.D, PhD, Clinical Director, Mclean Hospital
ClinicalTrials.gov Identifier: NCT01688765     History of Changes
Other Study ID Numbers: 2012P001796
Study First Received: September 17, 2012
Last Updated: September 17, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mclean Hospital:
Schizophrenia
Schizoaffective disorder
Bipolar disorder

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on November 25, 2014